Related Experiment Video
Updated: Feb 18, 2026
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Insights into Protein-Ligand Noncovalent Interaction Networks: A Database Survey and Quantum Chemistry Calculation
Ruitong Luo1,2, Zijian Han1,2, Jintian Li1,2
1State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
This study quantifies noncovalent interactions (NCIs) in protein-ligand binding. It reveals synergistic and antagonistic effects among halogen bonds, hydrogen bonds, cation-π interactions, π-π interactions, and salt bridges, guiding drug design.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Protein-ligand binding is crucial for biological processes and drug development.
- Multiple noncovalent interactions (NCIs) govern binding affinity, often exhibiting complex synergistic or antagonistic effects.
- Understanding these NCIs is key to rational drug design and optimization.
Purpose of the Study:
- To quantify the relationships and interplay among five major NCIs: halogen bonds (XB), hydrogen bonds (HB), cation-π interactions (CP), π-π interactions (PP), and salt bridges (SB).
- To investigate the synergistic and antagonistic effects of combined NCIs on protein-ligand binding.
- To provide insights for improving ligand design strategies through a deeper understanding of NCI networks.
Main Methods:
- Combined PDB statistical analysis with quantum mechanics/molecular mechanics (QM/MM) calculations.
- Quantified the energetic contributions and interplay of five key NCIs.
- Analyzed interaction distances to assess the enhancement of synergistic and antagonistic effects.
Main Results:
- Statistical analysis identified frequent interactions involving salt bridge (SB) acceptors, hydrogen bond (HB) acceptors, and halogen bond (XB) donors.
- Strongest antagonism was observed between cation-π (CP) acceptor and SB acceptor (median ΔEsyn = 1.31 kcal/mol).
- Strongest synergy was found between HB donor and acceptor (median ΔEsyn = -0.73 kcal/mol), with effects amplified at distances <7.5 Å.
- Three-NCI systems' energies were accurately predicted by summing two-NCI system energies (R² = 0.980).
Conclusions:
- A complex network of synergistic and antagonistic noncovalent interactions governs protein-ligand binding.
- Understanding these NCI interplay is essential for predicting binding affinity and designing effective ligands.
- The findings offer valuable guidance for rational ligand design in drug discovery.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
02:40Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:40Ligand Binding Sites
02:04Protein-protein Interfaces
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:18The Equilibrium Binding Constant and Binding Strength
02:18The Equilibrium Binding Constant and Binding Strength